Authors: Wielenga, VJM van der Neut, R Offerhaus, GJA Pals, ST

Citation: Vjm. Wielenga et al., CD44 glycoproteins in colorectal cancer: Expression, function, and prognostic value, ADV CANC R, 77, 2000, pp. 169-187

Authors: Wielenga, VJM van der Voort, R Taher, TEI Smit, L Beuling, EA van Krimpen, C Spaargaren, M Pals, ST

Citation: Vjm. Wielenga et al., Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer, AM J PATH, 157(5), 2000, pp. 1563-1573

Authors: Drillenburg, P Wielenga, VJM Kramer, MHH van Krieken, JHJM Kluin-Nelemans, HC Hermans, J Heisterkamp, S Noordijk, EM Kluin, PM Pals, ST

Citation: P. Drillenburg et al., CD44 expression predicts disease outcome in localized large B cell lymphoma, LEUKEMIA, 13(9), 1999, pp. 1448-1455

Authors: van der Voort, R Taher, TEI Wielenga, VJM Spaargaren, M Prevo, R Smit, L David, G Hartmann, G Gherardi, E Pals, ST

Citation: R. Van Der Voort et al., Heparan sulfate-modified CD44 promotes hepatocyte growth factor scatter factor induced signal transduction through the receptor tyrosine kinase c-Met, J BIOL CHEM, 274(10), 1999, pp. 6499-6506

Authors: Wielenga, VJM Smits, R Korinek, V Smit, L Kielman, M Fodde, R Clevers, H Pals, ST

Citation: Vjm. Wielenga et al., Expression of CD44 in Apc and Tcf mutant mice implies regulation by the WNT pathway, AM J PATH, 154(2), 1999, pp. 515-523